Onava
PrivateLast Round
Accelerator
Sep 2, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Onava is a biotechnology company that develops an AI-driven drug discovery platform combining generative models, protein engineering, and high-throughput wet-lab assays to accelerate the development of next-generation therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onava Comparables
Compare Onava with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DenovAI Biotech | 86% | |
| Sortera Bio | 84% | |
| EvolutionaryScale | 84% | |
Onava Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 2, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 41% MoM, from 2.1K to 3K.
- Apr 17, 2026
Monthly visitors increased 155% MoM, reaching 2.1K.
Onava Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Onava's valuation, stock price, and market status.